This study is NOT currently recruiting participants.
Number
03-EI-0033
Sponsoring Institute
National Eye Institute (NEI)
Recruitment Detail
Type: No longer recruiting/follow-up only Gender: Male & Female Min Age: 9 mo Max Age: 100 Years
Referral Letter Required
Yes
Population Exclusion(s)
None
Keywords
Retinoschisis; Genomic DNA; Pedigree Analysis; Genetic Analysis; Macular Degeneration; Natural History
Recruitment Keyword(s)
Condition(s)
Retinoschisis
Investigational Drug(s)
Investigational Device(s)
Intervention(s)
Supporting Site
National Eye Institute
Patients 9 months of age and older with XLRS and females who are suspected carriers of the gene responsible for the disease (such as the mother of the patient) may be eligible for this study. Other family members of patients also may be enrolled.
Patients will undergo the following tests and procedures:
- Personal and family medical history to review past and current medical conditions and treatments, particularly regarding eye disease, and to construct a family tree.
- Eye examination to assess visual acuity (eye chart test) and examine pupils, lens, retina, and eye movements. The pupils will be dilated with drops for this examination.
- Photography of the retina to help evaluate the status of the retina.
- Specialized eye tests to evaluate color vision, field of vision, and ability to see in the dark.
- Electroretinogram (ERG) to examine what happens to the eyes after a flash of bright light. For this test, the patient sits in a dark room for 30 minutes with his or her eyes patched. Then, a small silver disk electrode is taped to the forehead, the eye patches are removed, the surface of the eye is numbed with eye drops and contact lenses are placed on the eyes. The patient looks inside a large empty bowl and then a light flashes, first in the dark and then with a light turned on inside the bowl. The contact lenses sense small electrical signals generated by the retina when the light flashes.
- Blood test to examine DNA for genetic study of XLRS.
Family members will provide a blood sample for genetic study.
--Back to Top--
INCLUSION CRITERIA: Eligible participants must satisfy one of the criteria below: -Male diagnosed with X-Linked Juvenile Retinoschisis (proband). A proband will be defined as the first X-Linked Juvenile Retinoschisis diagnosed male in a given family who contacts the NIH for participation in the study; or -Female who is a suspected carrier (i.e., mother of proband); or -Other relative of proband including affected and unaffected males and females. The participant (or the participant s legal guardian) understands and signs this protocol s informed consent document and minor participants between the ages of 7 and 17 must provide assent. EXCLUSION CRITERIA: Affected males will be ineligible for participation if: -The participant has a significant media opacity or other obstruction precluding a complete fundus examination including retinal photography. -The participant is unwilling or unable to contribute a blood sample for genotyping if there is not existing genetic analysis data from a documented family member. Both affected and unaffected individuals will be ineligible for participation if: -The participant is younger than two years (seen at the NIH) or younger than nine months (participating offsite through medical record review and blood submission). -The participant is unable to cooperate with study procedures without anesthesia.
Eligible participants must satisfy one of the criteria below:
-Male diagnosed with X-Linked Juvenile Retinoschisis (proband). A proband will be defined as the first X-Linked Juvenile Retinoschisis diagnosed male in a given family who contacts the NIH for participation in the study; or
-Female who is a suspected carrier (i.e., mother of proband); or
-Other relative of proband including affected and unaffected males and females.
The participant (or the participant s legal guardian) understands and signs this protocol s informed consent document and minor participants between the ages of 7 and 17 must provide assent.
EXCLUSION CRITERIA:
Affected males will be ineligible for participation if:
-The participant has a significant media opacity or other obstruction precluding a complete fundus examination including retinal photography.
-The participant is unwilling or unable to contribute a blood sample for genotyping if there is not existing genetic analysis data from a documented family member.
Both affected and unaffected individuals will be ineligible for participation if:
-The participant is younger than two years (seen at the NIH) or younger than nine months (participating offsite through medical record review and blood submission).
-The participant is unable to cooperate with study procedures without anesthesia.
Principal Investigator
Referral Contact
For more information: